Yagi N - Search Results

1

Pharmacokinetics of ketotifen fumarate after intravenous, intranasal, oral and rectal administration in rabbits.

Yagi N, Taniuchi Y, Hamada K, Sudo J, Sekikawa H. Yagi N, et al. Biol Pharm Bull. 2002 Dec;25(12):1614-8. doi: 10.1248/bpb.25.1614. Biol Pharm Bull. 2002. PMID: 12499650 Free article.

2

Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol-polyvinylpyrrolidone in rabbits.

Kubo Y, Terashima Y, Yagi N, Nochi H, Tamoto K, Sekikawa H. Kubo Y, et al. Among authors: yagi n. Biol Pharm Bull. 2009 Nov;32(11):1880-4. doi: 10.1248/bpb.32.1880. Biol Pharm Bull. 2009. PMID: 19881302 Free article.

3

Biliary excretion of furosemide glucuronide in rabbits.

Sekikawa H, Yagi N, Oda K, Kenmotsu H, Takada M, Chen HF, Lin ET, Benet LZ. Sekikawa H, et al. Among authors: yagi n. Biol Pharm Bull. 1995 Mar;18(3):447-53. doi: 10.1248/bpb.18.447. Biol Pharm Bull. 1995. PMID: 7550101 Free article.

4

Sustained release of phenytoin following the oral administration of phenytoin sodium/ethylcellulose microcapsules in human subjects and rabbits.

Karakasa I, Yagi N, Shibata M, Kenmotsu H, Sekikawa H, Takada M. Karakasa I, et al. Among authors: yagi n. Biol Pharm Bull. 1994 Mar;17(3):432-6. doi: 10.1248/bpb.17.432. Biol Pharm Bull. 1994. PMID: 8019511 Free article.

5

Bioavailability and diuretic effect of bumetanide following rectal administration of suppositories containing weak acids in human subjects.

Yagi N, Kenmotsu H, Shimode Y, Oda K, Sekikawa H, Takada M. Yagi N, et al. Biol Pharm Bull. 1993 Nov;16(11):1124-9. doi: 10.1248/bpb.16.1124. Biol Pharm Bull. 1993. PMID: 8312869 Free article.

6

Enhanced absorption of bumetanide from suppositories containing weak acids in rabbits.

Yagi N, Kenmotsu H, Shimode Y, Oda K, Sekikawa H, Takada M. Yagi N, et al. Biol Pharm Bull. 1993 Mar;16(3):263-7. doi: 10.1248/bpb.16.263. Biol Pharm Bull. 1993. PMID: 8364470 Free article.

7

Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.

Yagi N, Kiuchi T, Satoh H, Terashima Y, Kenmotsu H, Sekikawa H, Takada M. Yagi N, et al. Biol Pharm Bull. 1996 Apr;19(4):616-22. doi: 10.1248/bpb.19.616. Biol Pharm Bull. 1996. PMID: 8860970 Free article.

8

Bioavailability and diuretic effect after administration of retarded capsules of bumetanide in human subjects.

Yagi N, Kiuchi T, Satoh H, Ishikawa Y, Takada M, Sekikawa H. Yagi N, et al. Biol Pharm Bull. 1999 Mar;22(3):275-80. doi: 10.1248/bpb.22.275. Biol Pharm Bull. 1999. PMID: 10220284 Free article.

9

Apparent intramolecular acyl migration and hydrolysis of furosemide glucuronide in aqueous solution.

Sekikawa H, Yagi N, Lin ET, Benet LZ. Sekikawa H, et al. Among authors: yagi n. Biol Pharm Bull. 1995 Jan;18(1):134-9. doi: 10.1248/bpb.18.134. Biol Pharm Bull. 1995. PMID: 7735228 Free article.

10

[Enhancement of rectal absorption of rifampicin by sodium para-aminosalicylate dihydrate in human subjects].

Suzuki R, Nakajima Y, Yagi N, Kenmotsu H, Sekikawa H, Miyazaki S, Mino K, Ohwada S, Kishi F, Hayashi N, et al. Suzuki R, et al. Among authors: yagi n. Yakugaku Zasshi. 1994 Nov;114(11):894-900. doi: 10.1248/yakushi1947.114.11_894. Yakugaku Zasshi. 1994. PMID: 7853151 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

814 results

Search Page

Filters